Movicol Paediatric Plain

Macrogol 3350, the active ingredient in Movicol Paediatric Plain, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the treatment of constipation in children, including faecal impaction, and may be used to prepare the bowel for diagnostic procedures.

GNH USA supplies Movicol Paediatric Plain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance, and reliable delivery across global markets today.

Movicol Paediatric Plain, an osmotic laxative, is used to manage conditions affecting bowel motility and stool consistency. - Constipation in children: softens stools and facilitates easier passage. - Faecal impaction: helps relieve hardened stool blockage in the colon. - Bowel preparation for diagnostic procedures: clears the intestinal tract to improve visualization. - Chronic functional constipation: promotes regular bowel movements and reduces stool hardness.

The most frequently reported reactions with Movicol Paediatric Plain are related to gastrointestinal tolerance, while rare events may indicate more serious concerns.

Common Side Effects: - Abdominal bloating - Nausea - Flatulence - Diarrhoea

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., hyponatraemia, hypokalaemia) - Allergic reactions such as rash or angio‑edema - Intense abdominal pain

Before initiating therapy with Movicol Paediatric Plain, consider the following precautions to ensure safe and effective use. - Assess hydration status: confirm adequate fluid intake before and during treatment. - Review electrolyte balance: monitor serum sodium and potassium, especially in patients with renal or cardiac disease. - Evaluate bowel obstruction risk: avoid use in known mechanical obstruction or severe ileus. - Adjust dose in renal impairment: consider reduced dosing or increased monitoring. - Use with caution in children with metabolic disorders: assess risk of electrolyte shifts. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Movicol Paediatric Plain may interact with other medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent use of other osmotic laxatives: may cause excessive fluid loss and electrolyte disturbances. - High‑dose electrolyte supplements (e.g., potassium chloride): increase risk of hyperkalaemia.

Moderate Interactions (Monitor Closely): - Anticholinergic agents (e.g., atropine): may reduce laxative efficacy. - Loop or thiazide diuretics: monitor electrolytes for additive effects. - Oral rehydration solutions: adjust electrolyte content to avoid imbalance. - Certain antibiotics (e.g., quinolones) that require optimal intestinal pH: monitor therapeutic levels.